March 2025 in “Human Genetics and Genomics Advances” This study found that genetic predictions of male pattern baldness from European populations do not generalize well to African populations, highlighting significant differences in genetic architecture between them.
This literature review examined topical treatments for various alopecia types, finding that minoxidil and corticosteroids are effective for multiple conditions, while JAK inhibitors show promise specifically for alopecia areata. The study emphasized the importance of individualized therapeutic approaches to enhance outcomes in hair loss management.
November 2024 in “International Journal of Innovative Science and Research Technology (IJISRT)” In this clinical study, 15 patients with osteoporosis treated with the Ayurvedic formulation Asthiposhtika Vati showed improvements in symptoms, suggesting its effectiveness in managing the condition.
September 2024 in “JAMA Dermatology” In this case series, low-dose oral metformin was associated with improvements in symptoms and gene expression changes in Black female patients with treatment-resistant central centrifugal cicatricial alopecia, suggesting a potential therapeutic role for metformin in managing this condition.
July 2024 in “Journal of Investigative Dermatology” This study investigated the potential mechanisms of Curcuma aeruginosa in treating androgenetic alopecia and identified 66 bioactive compounds interacting with proteins involved in the disorder, suggesting its involvement in hormone response and specific signaling pathways.
July 2024 in “Indian Journal of Dermatology Venereology and Leprology” This study found that specific PITX2 gene variants are significantly associated with higher risk of androgenetic alopecia in males, highlighting important genetic and environmental interactions influencing its development.
March 2024 in “Indian Journal of Dermatology/Indian journal of dermatology” This review discusses the potential of exosomes as cell-free treatments for skin aging and various dermatological diseases, highlighting their role in preventing scarring and promoting wound healing, while acknowledging the need for further research and quality control methodologies.
February 2024 in “arXiv (Cornell University)” In this study, researchers found that differences in skin condition distribution are the main source of errors when AI algorithms classify dermatological conditions from new, previously unseen sources, and proposed steps to improve their generalizability based on available information.
January 2024 in “bioRxiv (Cold Spring Harbor Laboratory)” This study found that genetic predictions of male pattern baldness derived from European data do not accurately predict baldness in African populations, highlighting significant continental differences in genetic architecture and evolutionary history.
January 2024 in “Updates in clinical dermatology” Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.
November 2023 in “JCEM Case Reports” In this case report, a 55-year-old postmenopausal woman was diagnosed with ovarian hyperthecosis as the cause of her hyperandrogenism after detailed hormonal and imaging investigations, which was successfully treated with bilateral salpingo-oophorectomy, leading to symptom improvement and normalized testosterone levels.
This case report describes retinal occlusion and medial canthal swelling in a 64-year-old female following the injection of acellular porcine urinary bladder matrix for hair restoration, a previously unreported side effect.
January 2023 in “Journal of The American Academy of Dermatology” This letter discusses the emergence of the dermatology hospitalist model and reports no new clinical outcomes; single institution studies suggest these services may enhance diagnostic accuracy and decrease readmissions.
December 2022 in “Journal of Phytonanotechnology and Pharmaceutical Sciences” This case report describes a 35-year-old woman with PCOS who achieved a healthy pregnancy and symptom relief through a four-month Ayurvedic treatment regimen, emphasizing its potential in treating severe cases.
This letter addresses feedback on a study about the effects of platelet-rich plasma on female androgenetic alopecia, particularly discussing the magnification choices for measuring hair density and caliber.
January 2021 in “arXiv (Cornell University)” This study found that self-supervised pretraining significantly improves accuracy in medical image classifiers for dermatology and chest X-ray tasks, outperforming supervised baselines and showing robustness to distribution shifts with limited labeled data.
January 2021 in “Pediatric Oncall” In this study, three patients with Type-1 autoimmune hepatitis experienced normalized liver enzymes and remission after six months of oral prednisolone treatment, while three others refused treatment.
January 2021 in “Dermatologic Therapy”
October 2020 in “Cirugía y cirujanos” This study found that severe obesity is positively associated with more severe lower urinary tract symptoms compared to moderate obesity in patients with prostatic enlargement.
November 2017 in “British Journal of Dermatology” The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.
May 2016 in “Endocrine Abstracts” Proximal hair cortisol is a reliable tool for diagnosing Cushing's Syndrome.
December 2015 in “Vascular Pharmacology” Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.
July 2014 in “Acupuncture & electro-therapeutics research” This study observed that certain changes in facial "heart representation areas," like eyebrow hair whitening and loss, are associated with cardiovascular issues and may correspond with increased Cardiac Troponin I levels.
September 2013 in “Neurodegenerative disease management” This review discusses teriflunomide as a disease-modifying therapy for multiple sclerosis and highlights its effectiveness and safety in clinical trials, but reports no new clinical results.
June 2011 in “CRC Press eBooks” Low-Level Laser Therapy can stimulate healing and cell function, potentially leading to wider medical use.
This abstract lists topics and hypotheses related to vitiligo and associated conditions but does not report any new research findings.
January 2021 in “European Journal of Molecular & Clinical Medicine”
This review discusses male androgenetic alopecia treatments, noting that topical minoxidil and oral finasteride are FDA-approved and require continuous use to maintain hair retention effects, but reports no new clinical results.
22 citations
,
September 2020 in “Journal of the American Academy of Dermatology” This study suggests that apremilast shows prolonged efficacy for up to 2 years in hidradenitis suppurativa patients who initially responded to the treatment, although further verification in a larger cohort is needed.